What is the current Diagnosis of Autoimmune Diseases market size?

The Diagnosis of Autoimmune Diseases market size is approximately USD 3.5 billion as of 2023.

What is the expected growth forecast for the Diagnosis of Autoimmune Diseases market?

The market is expected to grow at a CAGR of 7.2% from 2023 to 2030.

What are the major challenges facing the Diagnosis of Autoimmune Diseases market?

High costs of diagnostic tests and limited awareness in developing regions are major challenges.

Which regions are the leaders in the Diagnosis of Autoimmune Diseases market?

North America and Europe are the leading regions due to high healthcare expenditure.

Who are the top companies in the Diagnosis of Autoimmune Diseases market?

Top companies include Roche, Abbott, and Siemens Healthineers, offering innovative diagnostic solutions.

What future opportunities exist in the Diagnosis of Autoimmune Diseases market?

Emerging markets and advancements in AI-based diagnostic tools present future opportunities.

How does technology impact the Diagnosis of Autoimmune Diseases market?

Technological advancements in genomics and proteomics improve diagnostic accuracy and efficiency.

What is the current regulatory landscape for the Diagnosis of Autoimmune Diseases market?

Regulatory frameworks focus on ensuring safety and efficacy of diagnostic tests and devices.

What is the future outlook for the Diagnosis of Autoimmune Diseases market?

The future outlook is positive, driven by increasing demand for accurate diagnostic tests.

Diagnosis of Autoimmune Diseases Value Chain Analysis & Forecast Outlook 2033

Diagnosis of Autoimmune Diseases by Application (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other), by Types (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies & Immunologic Test, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Diagnosis of Autoimmune Diseases Market Size | CAGR 10.2 Forecast 2033

Diagnosis of Autoimmune Diseases Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Diagnosis of Autoimmune Diseases Market Overview

The Diagnosis of Autoimmune Diseases market refers to the industry involved in the development and implementation of diagnostic tests and tools for autoimmune diseases. The Diagnosis of Autoimmune Diseases market size is estimated to be around $4.8 billion in 2025. As the prevalence of autoimmune diseases continues to rise, the growth outlook for the Diagnosis of Autoimmune Diseases market is expected to be positive, with a market forecast of $8.5 billion by 2033. This industry expansion is driven by the increasing demand for accurate and efficient diagnostic tests, and the market forecast indicates a compound annual growth rate (CAGR) of 7.5% during the forecast period. Key forces shaping the industry include technology shifts, such as the adoption of artificial intelligence and machine learning, regulations, such as those related to patient data protection, and consumer behavior, such as the increasing awareness of autoimmune diseases. The largest region for the Diagnosis of Autoimmune Diseases market is North America, while the fastest-growing region is Asia-Pacific.

Loading chart…

The Diagnosis of Autoimmune Diseases market is expected to witness significant growth during the forecast period, driven by the increasing prevalence of autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis. The market growth is also driven by the increasing adoption of advanced diagnostic technologies, such as next-generation sequencing and nanotechnology. The Asia-Pacific region is expected to be the fastest-growing region, driven by the increasing awareness of autoimmune diseases and the growing demand for diagnostic tests in countries such as China and India. Overall, the Diagnosis of Autoimmune Diseases market is expected to provide significant opportunities for growth and investment during the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	27.84 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Siemens Healthineers; Inova Diagnostics; GRIFOLS; Danaher; Bio-Rad Laboratories; Abbott; Trinity Biotech; Werfen; Protagen; HYCOR Biomedical; HTG Molecular Diagnostics; EUROIMMUN AG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Diagnosis of Autoimmune Diseases market is experiencing significant transformations, driven by various factors. To understand the market dynamics, it is essential to analyze the growth drivers, restraints, opportunities, and challenges that are shaping the Diagnosis of Autoimmune Diseases market size and growth forecast.

Growth Drivers2 items

Increasing prevalence of autoimmune diseases, such as rheumatoid arthritis and lupus, is driving the demand for accurate and efficient diagnostic tests, thereby contributing to the growth of the Diagnosis of Autoimmune Diseases market.

Advances in technology, including the development of biomarkers and next-generation sequencing, are enabling the creation of more precise and reliable diagnostic tools, which is expected to propel the Diagnosis of Autoimmune Diseases market size in the coming years.

Restraints2 items

High costs associated with the development and implementation of advanced diagnostic tests are limiting their adoption, particularly in resource-constrained settings, and hindering the growth of the Diagnosis of Autoimmune Diseases market.

Stringent regulatory requirements and the need for rigorous testing and validation of diagnostic tests are creating barriers to entry for new market players and slowing down the growth forecast of the Diagnosis of Autoimmune Diseases market.

Opportunities2 items

The growing focus on personalized medicine and targeted therapies is creating opportunities for the development of novel diagnostic tests and treatments for autoimmune diseases, which is expected to drive the Diagnosis of Autoimmune Diseases market size in the future.

Increasing collaborations and partnerships between pharmaceutical companies, research institutions, and diagnostic manufacturers are facilitating the development of innovative diagnostic solutions and driving growth in the Diagnosis of Autoimmune Diseases market.

Challenges2 items

The complex and heterogeneous nature of autoimmune diseases is making it challenging to develop diagnostic tests that can accurately identify and distinguish between different conditions, which is a significant challenge for the Diagnosis of Autoimmune Diseases market.

The need for standardization and harmonization of diagnostic tests and protocols across different regions and healthcare systems is a major challenge that must be addressed to ensure the accurate and reliable diagnosis of autoimmune diseases and to support the growth forecast of the Diagnosis of Autoimmune Diseases market.

Market Segmentation

Loading chart…

The Application segment in the Diagnosis of Autoimmune Diseases market refers to the various uses of diagnostic tests and techniques for autoimmune diseases. This segment is crucial in understanding the Diagnosis of Autoimmune Diseases segmentation as it highlights the different areas where these tests are applied, such as rheumatoid arthritis, lupus, and thyroid diseases. The application segment contributes significantly to the overall market size, with a substantial portion of the revenue generated from the diagnosis and monitoring of these diseases.

The Types segment in the Diagnosis of Autoimmune Diseases market encompasses various subtypes, including type 1 diabetes, rheumatoid arthritis, and systemic lupus erythematosus. Each subtype has distinct diagnostic requirements, contributing to the overall market size. Understanding the different types of autoimmune diseases is essential for market taxonomy, as it allows for the development of targeted diagnostic solutions. The types segment plays a vital role in shaping the market landscape, with each subtype presenting unique opportunities and challenges for diagnostic test manufacturers.

Diagnosis of Autoimmune Diseases Segmentation Breakdown12 items

Application

Rheumatoid Arthritis

Systemic Lupus Erythematosus

Sjögren’s Syndrome

Thyroiditis

Scleroderma

Other

Types

Routine Laboratory Tests

Inflammatory Markers

Autoantibodies & Immunologic Test

Other

Regional Insights

Loading chart…

The Diagnosis of Autoimmune Diseases market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - established ecosystem maturity, high demographics awareness, and significant investments in research and development; Europe - adoption of innovative diagnostic technologies, favorable policies, and a well-established infrastructure; Asia Pacific - growing demographics, increasing adoption of digital health technologies, and significant investments in healthcare infrastructure; Latin America - improving infrastructure, increasing adoption of diagnostic technologies, and favorable policies; Middle East & Africa - growing demographics, increasing investments in healthcare infrastructure, and improving ecosystem maturity.

The regional forecast indicates a significant Diagnosis of Autoimmune Diseases market growth in Asia Pacific, driven by the region's large and growing population, increasing adoption of advanced diagnostic technologies, and significant investments in healthcare infrastructure. In contrast, North America and Europe are expected to experience steady growth, driven by established ecosystem maturity and high demographics awareness.

Competitive Landscape

The Diagnosis of Autoimmune Diseases competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by a combination of these factors, with global players focusing on product innovation and local companies competing on pricing and distribution.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. The following companies have adopted various strategic focuses:

Thermo Fisher Scientific: regional expansion

Siemens Healthineers: innovation pipeline

Inova Diagnostics: premium pricing

GRIFOLS: vertical integration

Danaher: OEM tie-ups

Bio-Rad Laboratories: local manufacturing

Key Diagnosis of Autoimmune Diseases Companies13 items

Thermo Fisher Scientific

Siemens Healthineers

Inova Diagnostics

GRIFOLS

Danaher

Bio-Rad Laboratories

Abbott

Trinity Biotech

Werfen

Protagen

HYCOR Biomedical

HTG Molecular Diagnostics

EUROIMMUN AG

Market Ecosystem

The Diagnosis of Autoimmune Diseases ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. At its core, the ecosystem involves the creation and capture of value through the development, integration, and delivery of diagnostic solutions. Technology providers and suppliers form the upstream foundation, while integrators, channels, and end users comprise the midstream and downstream segments. Understanding the Diagnosis of Autoimmune Diseases ecosystem is crucial for navigating the intricate relationships and interactions that shape this market.

Raw material/component suppliers — providing diagnostic reagents

Technology providers — developing diagnostic platforms

OEMs / manufacturers — producing diagnostic equipment

System integrators / EPCs — integrating diagnostic systems

Distributors / channel partners — delivering diagnostic solutions

Service providers / after-sales — offering maintenance and support

Regulators/standards bodies — establishing diagnostic standards

As value flows through the Diagnosis of Autoimmune Diseases ecosystem, control points emerge, influencing adoption and dependency risks. Regulators and standards bodies exert significant influence over the development and approval of diagnostic solutions, while technology providers and suppliers can create bottlenecks due to input constraints or limited availability of key components. Furthermore, switching costs, partnerships, and interoperability requirements can also impact the ecosystem, with regional differences in regulatory frameworks and market dynamics introducing additional complexities.

Recent Industry Insights

The Diagnosis of Autoimmune Diseases industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies and research institutions have led to advancements in diagnostic technologies. Mergers and acquisitions have also been on the rise, with companies like Roche and Abbott expanding their portfolios in the autoimmune disease diagnosis space. Furthermore, product launches such as novel biomarkers and artificial intelligence-based diagnostic tools have improved diagnosis accuracy and efficiency.

Regulatory changes, including the approval of new diagnostic tests by the US FDA, have also driven growth in the industry. Additionally, a shift in consumer trends towards personalized medicine and preventive care has increased demand for early and accurate diagnosis of autoimmune diseases. Funding rounds and expansions by companies like Illumina and Thermo Fisher have also supported research and development in the field, contributing to the overall growth of the Diagnosis of Autoimmune Diseases industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Diagnosis of Autoimmune Diseases market outlook. The market attractiveness is driven by the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies. The competitive intensity is moderate, with key players investing in research and development to improve diagnostic accuracy and efficiency. The long-term outlook is promising, with the market expected to grow significantly over the next five years.

The innovation landscape is characterized by the development of novel biomarkers and advanced imaging technologies. The demand-supply balance is expected to be stable, with increasing demand for diagnostic services driving the growth of the market. However, key risk factors include regulatory changes and reimbursement challenges. Overall, the Diagnosis of Autoimmune Diseases market presents opportunities for growth and innovation, driven by the need for accurate and efficient diagnostic solutions.

11 items

1. Executive Summary

2. Diagnosis of Autoimmune Diseases Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Diagnosis of Autoimmune Diseases Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Diagnosis of Autoimmune Diseases Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Rheumatoid Arthritis

6.1.2. Systemic Lupus Erythematosus

6.1.3. Sjögren’s Syndrome

6.1.4. Thyroiditis

6.1.5. Scleroderma

6.1.6. Other

6.2. Global Diagnosis of Autoimmune Diseases Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Routine Laboratory Tests

6.2.2. Inflammatory Markers

6.2.3. Autoantibodies & Immunologic Test

6.2.4. Other

6.3. Global Diagnosis of Autoimmune Diseases Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Diagnosis of Autoimmune Diseases Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Diagnosis of Autoimmune Diseases Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Diagnosis of Autoimmune Diseases Market Competition by Key Manufacturers

8.1. Global Diagnosis of Autoimmune Diseases Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Diagnosis of Autoimmune Diseases: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Siemens Healthineers

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Inova Diagnostics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. GRIFOLS

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Danaher

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Bio-Rad Laboratories

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Abbott

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Trinity Biotech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Werfen

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Protagen

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. HYCOR Biomedical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. HTG Molecular Diagnostics

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. EUROIMMUN AG

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Diagnosis of Autoimmune Diseases Market

Figure 4: Global Diagnosis of Autoimmune Diseases Market: Drivers

Figure 5: Global Diagnosis of Autoimmune Diseases Market: Challenges

Figure 6: Global Diagnosis of Autoimmune Diseases Market: Trends

Figure 7: Global Diagnosis of Autoimmune Diseases Market: Opportunity

Figure 8: Global Diagnosis of Autoimmune Diseases Market: Restraint

Figure 9: Global Diagnosis of Autoimmune Diseases Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Diagnosis of Autoimmune Diseases Market Value (USD Million) By Region

Figure 15: Global Diagnosis of Autoimmune Diseases Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Diagnosis of Autoimmune Diseases Market Value (USD Million) By Region

Figure 23: Global Diagnosis of Autoimmune Diseases Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Diagnosis of Autoimmune Diseases Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Diagnosis of Autoimmune Diseases Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Diagnosis of Autoimmune Diseases Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Diagnosis of Autoimmune Diseases Market Value (USD Million) By Region

Table 10: Global Diagnosis of Autoimmune Diseases Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Diagnosis of Autoimmune Diseases Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Diagnosis of Autoimmune Diseases Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Diagnosis of Autoimmune Diseases Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: Siemens Healthineers Basic Information And Sales Area

Table 33: Siemens Healthineers. Products Portfolio

Table 34: Inova Diagnostics Basic Information And Sales Area

Table 35: Inova Diagnostics. Products Portfolio

Table 36: GRIFOLS Basic Information And Sales Area

Table 37: GRIFOLS. Products Portfolio

Table 38: Danaher Basic Information And Sales Area

Table 39: Danaher. Products Portfolio

Table 40: Bio-Rad Laboratories Basic Information And Sales Area

Table 41: Bio-Rad Laboratories. Products Portfolio

Table 42: Abbott Basic Information And Sales Area

Table 43: Abbott. Products Portfolio

Table 44: Trinity Biotech Basic Information And Sales Area

Table 45: Trinity Biotech. Products Portfolio

Table 46: Werfen Basic Information And Sales Area

Table 47: Werfen. Products Portfolio

Table 48: Protagen Basic Information And Sales Area

Table 49: Protagen. Products Portfolio

Table 50: HYCOR Biomedical Basic Information And Sales Area

Table 51: HYCOR Biomedical. Products Portfolio

Table 52: HTG Molecular Diagnostics Basic Information And Sales Area

Table 53: HTG Molecular Diagnostics. Products Portfolio

Table 54: EUROIMMUN AG Basic Information And Sales Area

Table 55: EUROIMMUN AG. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Diagnosis of Autoimmune Diseases Market Value (USD Million) By Region

Table 61: Global Diagnosis of Autoimmune Diseases Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Diagnosis of Autoimmune Diseases Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	27.84 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Siemens Healthineers; Inova Diagnostics; GRIFOLS; Danaher; Bio-Rad Laboratories; Abbott; Trinity Biotech; Werfen; Protagen; HYCOR Biomedical; HTG Molecular Diagnostics; EUROIMMUN AG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options